Literature DB >> 24165726

Linking the SWI/SNF complex to prostate cancer.

Ryan S Lee1, Charles W M Roberts.   

Abstract

Genes encoding subunits of the SWI/SNF chromatin-remodeling complex constitute, collectively, one of the most frequently mutated targets in cancer. Although mutations in SWI/SNF genes are uncommon in prostate cancer, a new study shows that SChLAP1, a long noncoding RNA frequently expressed in aggressive prostate tumors, drives cancer by directly disrupting SNF5, a core subunit of the SWI/SNF complex.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24165726     DOI： 10.1038/ng.2805

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  15 in total

Review 1.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

2.  Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.

Authors:  Cigall Kadoch; Gerald R Crabtree
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

3.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

Review 4.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

5.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

6.  Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Authors:  Kevin A Link; Sucharitha Balasubramaniam; Ankur Sharma; Clay E S Comstock; Sonia Godoy-Tundidor; Nathan Powers; Khanh H Cao; Annemie Haelens; Frank Claessens; Monica P Revelo; Karen E Knudsen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

7.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.

Authors:  John R Prensner; Matthew K Iyer; O Alejandro Balbin; Saravana M Dhanasekaran; Qi Cao; J Chad Brenner; Bharathi Laxman; Irfan A Asangani; Catherine S Grasso; Hal D Kominsky; Xuhong Cao; Xiaojun Jing; Xiaoju Wang; Javed Siddiqui; John T Wei; Daniel Robinson; Hari K Iyer; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

8.  The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.

Authors:  John R Prensner; Matthew K Iyer; Anirban Sahu; Irfan A Asangani; Qi Cao; Lalit Patel; Ismael A Vergara; Elai Davicioni; Nicholas Erho; Mercedeh Ghadessi; Robert B Jenkins; Timothy J Triche; Rohit Malik; Rachel Bedenis; Natalie McGregor; Teng Ma; Wei Chen; Sumin Han; Xiaojun Jing; Xuhong Cao; Xiaoju Wang; Benjamin Chandler; Wei Yan; Javed Siddiqui; Lakshmi P Kunju; Saravana M Dhanasekaran; Kenneth J Pienta; Felix Y Feng; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2013-09-29       Impact factor: 38.330

9.  SNF5 is an essential executor of epigenetic regulation during differentiation.

Authors:  Jueng Soo You; Daniel D De Carvalho; Chao Dai; Minmin Liu; Kurinji Pandiyan; Xianghong J Zhou; Gangning Liang; Peter A Jones
Journal:  PLoS Genet       Date:  2013-04-25       Impact factor: 5.917

10.  Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.

Authors:  Zhou Du; Teng Fei; Roel G W Verhaak; Zhen Su; Yong Zhang; Myles Brown; Yiwen Chen; X Shirley Liu
Journal:  Nat Struct Mol Biol       Date:  2013-06-02       Impact factor: 15.369
View more
  19 in total

Review 1.  Long non-coding RNAs: the tentacles of chromatin remodeler complexes.

Authors:  Audrey Vincent; Isabelle Van Seuningen; Bernadette Neve; Nicolas Jonckheere
Journal:  Cell Mol Life Sci       Date:  2020-10-01       Impact factor: 9.261

2.  Mechanism of long noncoding RNAs as transcriptional regulators in cancer.

Authors:  Yan Huang; Qi Guo; Xi-Ping Ding; Xiangting Wang
Journal:  RNA Biol       Date:  2020-01-10       Impact factor: 4.652

Review 3.  Exosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer.

Authors:  Rajib Dhar; Saurav Mallik; Arikketh Devi
Journal:  3 Biotech       Date:  2022-06-26       Impact factor: 2.893

4.  Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.

Authors:  Aya Misawa; Ken-Ichi Takayama; Tomohiko Urano; Satoshi Inoue
Journal:  J Biol Chem       Date:  2016-06-24       Impact factor: 5.157

5.  The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.

Authors:  Romain Tropée; Bárbara de la Peña Avalos; Madeline Gough; Cameron Snell; Pascal H G Duijf; Eloïse Dray
Journal:  Breast Cancer Res Treat       Date:  2020-11-12       Impact factor: 4.872

6.  BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.

Authors:  Aktan Alpsoy; Sagar M Utturkar; Benjamin C Carter; Alisha Dhiman; Sandra E Torregrosa-Allen; Melanie P Currie; Bennett D Elzey; Emily C Dykhuizen
Journal:  Cancer Res       Date:  2020-12-21       Impact factor: 13.312

Review 7.  Chromatin Remodelers: From Function to Dysfunction.

Authors:  Gernot Längst; Laura Manelyte
Journal:  Genes (Basel)       Date:  2015-06-12       Impact factor: 4.096

8.  A polymorphism rs12325489C>T in the lincRNA-ENST00000515084 exon was found to modulate breast cancer risk via GWAS-based association analyses.

Authors:  Na Li; Ping Zhou; Jian Zheng; Jieqiong Deng; Hongchun Wu; Wei Li; Fang Li; Hongbin Li; Jiachun Lu; Yifeng Zhou; Chun Zhang
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

9.  Analysis of tumor suppressor genes based on gene ontology and the KEGG pathway.

Authors:  Jing Yang; Lei Chen; Xiangyin Kong; Tao Huang; Yu-Dong Cai
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

10.  SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.

Authors:  Zhao-Ming Xiao; Dao-Jun Lv; Yu-Zhong Yu; Chong Wang; Tao Xie; Tao Wang; Xian-Lu Song; Shan-Chao Zhao
Journal:  Front Cell Dev Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.